2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.
A high volume of FDA approvals for new tests and diagnostic products made up for the relatively low number of approvals in the EU.
Automating travel and expense significantly improves performance, but adding mobility takes such improvements to a much higher level.
The recent FDA approval of an OTC test shows that COVID-19 saliva testing may be poised for bigger and better things in the years ahead.
Though only seven transactions were announced or closed in November, two were billion-dollar deals.
Key cases over the past month were the usual FCA-related fare, apart from a dismissed sex discrimination case.
It’s important to have a clear policy in place for approving remote work requests and ensuring employees remain productive.
Federal enforcement actions at the end of October and first two weeks of November featured some unusual characters.
Could not following MAC guidance constitute evidence that a party knowingly submitted, or caused the submission of, false claims?
There are potentially significant legal ramifications of employing digital nomads who work from abroad—for both you and your employee.